“…Along with the well‐known predilection sites (that is, cerebellar cortex, dentate nucleus and inferior olive) [7,8,10–15], the neuropathological process involved the cerebellar fastigial, globose and emboliform nuclei, the allocortex and neocortex, the thalamus, the midbrain dopaminergic system, as well as a variety of oculomotor, auditory, vestibular, ingestion‐related, somatosensory and precerebellar brainstem nuclei. These novel findings confirm recent clinical symptom‐based assumptions that brain damage in SCA6 may go beyond the well‐known cerebellar and brainstem predilection sites [3,5,7,9,19] and that the substantia nigra and the pyramidal system may be affected in SCA6 [16,18,20]. Although in the SCA6 patients studied here, the extent of brain damage displayed some overlap with those commonly seen in terminal SCA2, SCA3 and SCA7 patients, it was less pronounced and, in contrast to terminal SCA2, SCA3 and SCA7 patients, did not include atrophy of central nervous fibre tracts or extracerebellar myelin loss [21,25,42–49].…”